Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hi-Tech Spring Chemical is a leading global manufacturer of high-purity pharmaceutical excipients and fine chemicals. The company specializes in the production of pharmaceutical-grade propylene glycol, dipropylene glycol, and dimethyl carbonate, which are essential components in drug delivery and formulation. Their products are designed to meet rigorous international standards, including USP, EP, and JP pharmacopoeias, making them a critical supplier for the global pharmaceutical industry. Hi-Tech Spring operates advanced manufacturing facilities in China and is publicly traded on the Shenzhen Stock Exchange. The company's focus on quality and regulatory compliance has established it as a key partner for major pharmaceutical companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hi-Tech Spring.